The 2024 PM360 Pharma Choice Awards – Multichannel Silver Winner

Luminous Creative Imaging, Ogilvy Health, and Ferring Pharmaceuticals Inc.

Bugs of Paradise

The REBYOTA campaign features a juxtaposition of the desolate barrens and lush flora. The imagery symbolizes the impact of delivering diverse bacteria direct to the gut microbiome with REBYOTA to prevent the recurrence of C. difficile infection and restore hope to patients—delivered in a strategic and innovative channel mix.

FERRING PHARMACEUTICALS TEAM MEMBERS:
David Bell Commercialization Lead – Microbiome
Jennifer Accumanno Director, HCP Marketing – Microbiome and GI
Christina Cirasuolo Senior Manager, HCP Marketing – Microbiome
Ashley Villani Manger, Marketing – Microbiome

OGILVY HEALTH TEAM MEMBERS:
Deborah Ciauro Executive Creative Director
George Giunta VP, Group Creative Director
Lori Lagitch Associate Creative Director
Mike Brune Executive Creative Director
Bryan Minogue Associate Creative Director
Julieta Smith SVP, Planner
Julia Weiss Director, UX & Content Strategy
Laura Schember Client Engagement Officer
Avery (Riggs) Stephens Senior Account Executive
Beth Lamlamay VP, Director of Project Management

Ads

You May Also Like

2023 Pharma Choice Video Bronze Winner Scientific Global and Avion Pharmaceuticals, Women’s Health

Scientific Global and Avion Pharmaceuticals, Women’s Health Uniquely Hers Webcast Talk show versus “talking head.” ...

HealthcareWATCH

DISCOVERIES & INNOVATION CAR T Cells May Be the Answer to a Longer Life ...

2019 Pharma Choice App Bronze Winner Synapse and AstraZeneca

Synapse AstraZeneca BiomARker Experience App To encourage physicians to optimize their biomarker testing process, ...